No Data
No Data
Shanghai Fosun Pharma Announces Capital Reduction
Shareholder anhui sunhere pharmaceutical excipients (300452.SZ) shareholding fosun pharma accumulatively reduced 2.8263 million shares.
Anhui Sunhere Pharmaceutical Excipients (300452.SZ) announced that shareholder Fosun Pharma acquired from June 15, 2020 to...
fosun pharma (02196) obtained the controlling shareholder fosun technology to release the pledge of 0.13 billion shares of A shares
Fosun Pharma (02196) announced that the company received a notice from its controlling shareholder Shanghai Fosun on October 8, 2024...
Trending Industry Today: FOSUN PHARMA Leads Losses In Aesthetic Medicine Stocks
Trending Industry Today: SIHUAN PHARM Leads Gains In Aesthetic Medicine Stocks
HK Stock Market Update: Fosun Pharma (02196) surged over 11% in the morning session. Recently, its subsidiary's treatment for colorectal cancer was approved for listing by the National Medical Products Administration.
Fosun Pharma (02196) surged more than 11% in early trading, as of the time of publication, up by 11.05%, at 18.7 Hong Kong dollars, with a transaction volume of 0.1 billion Hong Kong dollars.
No Data
No Data